A Blue Ash-based medical device aims to use new capital to help get its products into surgeons' hands.
On Tuesday, Standard Bariatrics announced it landed $35 million in Series B capital led by Silicon Valley-based U.S. Venture Partners, which specializes in early-stage ventures in enterprise software, cyber security, consumer, e-commerce, health care and IT-enabled health care services.
Standard Bariatrics is the maker of the Titan SGS, a stapling technology designed specifically for surgery related to obesity. The device received clearance from the U.S. Food and Drug Administration in April.
In a statement, CEO Matt Sokany said the new capital will allow Standard Bariatrics to scale its commercialization plans for its products, which also includes the Standard Clamp, a disposable device that can be used by surgeons performing laparoscopic sleeve gastrectomy, a common weight loss procedure.
As part of the latest funding round, Cincinnati-based River Cities Capital made its first investment in Standard Bariatrics, joining the company's Series A syndication investors. Those investors, who reupped in the most recent round, include: RiverVest Venture Partners, Hatteras Venture Partners, Queen City Angels and Emergent Medical Partners.
CincyTech previously invested an undisclosed amount in Standard Bariatrics in 2016.
